Anamnesis |
When assessing a patient with suspected RPE65 mutation-associated inherited retinal disease, the anamnesis (medical history) must include: |
General ophthalmologic history |
Symptoms at onset |
Age at symptom onset |
Pedigree |
Inquiry about consanguinity |
Existence of other affected family members |
Signs of disease progression |
Previous/current therapy for ocular diseases |
Other previous visits to a general ophthalmologist or to a retina specialist |
Previous clinical assessment for vision (MRI, OCT, ERG, FAF) |
Presence or not of neurological or extra-ocular symptoms |
General pharmacologic history and ongoing medical treatments |
History of infectious diseases |
Other diseases |
Patient expectations |
Professional activities and lifestyle (for adult patients) |
Genetic testing |
Genetic testing for diagnosis must be carried out by certified laboratories |
The certification of a genetic diagnostic laboratory is defined by the following criteria |
ISO certification |
Analysis of > 100 cases per year for genetic diagnosis and document a highly significant number of confirmed genetic diagnosis cases |
Being part of a network with medical geneticists and inherited retinal diseases specialists from other national and international centres |
The certified laboratories conducting genetic testing for inherited retinal disease diagnosis must |
Have qualified geneticists with consolidated expertise in the genetics of hereditary retinal dystrophies |
Have standardised internal molecular analysis protocols |
Perform genetic counselling before and after testing |
Be part of a national diagnostic laboratories network and/or Genetic Scientific Society (e.g., SIGU) |
Rely on a complete multidisciplinary team (geneticists, retina specialist, molecular biologists, technicians, bioinformatician, genetic counsellor) already familiar with IRDs molecular diagnosis |
Be able to perform MLPA analysis |
Be able to perform both Sanger and multi-gene NGS tests |
Be able to perform in silico analysis |
Be able to perform in vitro protein functional assessment |
Participate in inherited retinal disease national/international registries |
A qualified geneticist is defined as a geneticist with |
Consolidated expertise in the genetics of hereditary retinal dystrophies |
Updated knowledge of the state-of-the-art and proven track record in the field of genetics of IRDs |
Relevant published literature in the field |
Proactive interactions and collaborations with international counterparts as part of multicentre consortia |
Active networking with national and international counterparts is particularly important for a qualified geneticist |
In the case of rare diseases with high genetic heterogeneity like RPE65-associated Inherited retinal disease |
To exchange knowledge and expertise with other geneticists and IRD specialists |